DoW Pancreatic Cancer Research Program, Translational Research Partnership Award
This grant funds collaborative projects between scientists and clinicians to advance promising pancreatic cancer research toward clinical application, requiring two principal investigators and preliminary supporting data.
Funder: Dept. of the Army -- USAMRAA
Due Dates: July 7, 2026: Pre-Application | October 7, 2026: Full Application | October 13, 2026: Application Verification Deadline
Funding Amounts: ~$6.6M total; up to ~$1.1M total costs per partnership (max 3 years); ~6 awards expected
Summary: Supports partnerships to accelerate translational research in pancreatic cancer, moving promising ideas toward clinical application.
Key Information: Requires two PIs (Initiating and Partnering); preliminary data are required; pilot clinical trials allowed but not large-scale trials.
Description
This opportunity supports collaborative translational research projects in pancreatic cancer, aiming to rapidly advance promising concepts toward clinical application. The mechanism requires a partnership between two independent investigators—one Initiating PI and one Partnering PI—each contributing unique expertise. Projects must address at least one of the FY26 Pancreatic Cancer Research Program (PCARP) Focus Areas, such as early detection, risk identification, survivorship, biomarkers, or novel therapeutic strategies. The award is designed to foster synergy between basic, applied, clinical, and population scientists, with a strong emphasis on moving research findings into practice to benefit patients, including Service Members, Veterans, and the broader public.
